4.7 Article

Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus

Harold Bays

CURRENT MEDICAL RESEARCH AND OPINION (2009)